Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Himmelmann

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Lakartidningen|April 15, 2006
[Fibrates, nicotinic acid preparations and muscular pain]Asa Kindstedt, Anders Himmelmann
Blood Pressure|November 17, 2004
Cardiovascular complications of COX2 selective inhibitors cause considerable concernThomas Hedner, Anders Himmelmann
Blood Pressure|April 3, 2002
The price you pay for hypertension management: incorporation of economic factors into clinical decision makingAnders Himmelmann, Lannart Hansson, Thomas Hedner
Blood Pressure|January 14, 2003
Blood pressure measurement: a century of achievements and improvements in the year 2002Anders Himmelmann, Lennart Hansson, Thomas Hedner
Blood Pressure|July 20, 2002
Researchers receive record compensation from TV company for media insult linked to the calcium antagonist controversyLennart Hansson, Thomas Hedner, Anders Himmelmann
Future Cardiology|May 11, 2016
Ticagrelor for the treatment of atherosclerotic disease: insights from the PARTHENON clinical development programPeter Held, Anders Himmelmann, Marc Ditmarsch
Blood Pressure|April 21, 2017
Endothelial Dysfunction - A Challenge for Hypertension ResearchThomas Hedner, Lennart Hansson, Anders Himmelmann
Blood Pressure|October 4, 2002
Homocysteine and ADMA--emerging risk factors for cardiovascular disease?Thomas Hedner, Anders Himmelmann, Lennart Hansson
Blood Pressure|June 30, 2004
Cardiovascular risk stratification: an important tool for treatment to lower cardiovascular disease riskAnders Himmelmann, Sverre Kjeldsen, Thomas Hedner
Blood Pressure|June 12, 2003
Contrasting messages but not contradicting results from ALLHAT and ANBP2Thomas Hedner, Anders Himmelmann, Sverre E Kjeldsen
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Lakartidningen|April 15, 2006
[Fibrates, nicotinic acid preparations and muscular pain]Asa Kindstedt, Anders Himmelmann
Blood Pressure|November 17, 2004
Cardiovascular complications of COX2 selective inhibitors cause considerable concernThomas Hedner, Anders Himmelmann
Blood Pressure|April 3, 2002
The price you pay for hypertension management: incorporation of economic factors into clinical decision makingAnders Himmelmann, Lannart Hansson, Thomas Hedner
Blood Pressure|January 14, 2003
Blood pressure measurement: a century of achievements and improvements in the year 2002Anders Himmelmann, Lennart Hansson, Thomas Hedner
Blood Pressure|July 20, 2002
Researchers receive record compensation from TV company for media insult linked to the calcium antagonist controversyLennart Hansson, Thomas Hedner, Anders Himmelmann
Future Cardiology|May 11, 2016
Ticagrelor for the treatment of atherosclerotic disease: insights from the PARTHENON clinical development programPeter Held, Anders Himmelmann, Marc Ditmarsch
Blood Pressure|April 21, 2017
Endothelial Dysfunction - A Challenge for Hypertension ResearchThomas Hedner, Lennart Hansson, Anders Himmelmann
Blood Pressure|October 4, 2002
Homocysteine and ADMA--emerging risk factors for cardiovascular disease?Thomas Hedner, Anders Himmelmann, Lennart Hansson
Blood Pressure|June 30, 2004
Cardiovascular risk stratification: an important tool for treatment to lower cardiovascular disease riskAnders Himmelmann, Sverre Kjeldsen, Thomas Hedner
Blood Pressure|June 12, 2003
Contrasting messages but not contradicting results from ALLHAT and ANBP2Thomas Hedner, Anders Himmelmann, Sverre E Kjeldsen
Pageof 10